Literature DB >> 25591984

Metabolic risk in PCOS: phenotype and adiposity impact.

Lisa J Moran1, Robert J Norman2, Helena J Teede3.   

Abstract

Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women, with reproductive, cardiometabolic, and psychological features. The heterogeneity in insulin resistance, obesity, and cardiometabolic features has led to controversy on the independent contributions of PCOS status, diagnostic criteria, phenotype, and adiposity. It now appears that women with PCOS have an increased risk of insulin resistance and cardiometabolic features, which is independent of, but worsened by, adiposity and central adiposity, and is unrelated to reproductive phenotype. Obesity may be more prevalent in the more severe phenotypes, which suggests either an exacerbation of the reproductive features or a more likely diagnosis in overweight women with PCOS. Therefore, all women with PCOS should be targeted for prevention, screening, and management of cardiometabolic features.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cardiometabolic; diagnostic criteria; insulin resistance; obesity; polycystic ovary syndrome

Mesh:

Year:  2015        PMID: 25591984     DOI: 10.1016/j.tem.2014.12.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  60 in total

1.  Epigenetic regulation of traf2- and Nck-interacting kinase (TNIK) in polycystic ovary syndrome.

Authors:  Da Li; Jiao Jiao; Yi-Ming Zhou; Xiu-Xia Wang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 2.  Optimizing reproductive health in women with obesity and infertility.

Authors:  Matea Belan; Soren Harnois-Leblanc; Blandine Laferrère; Jean-Patrice Baillargeon
Journal:  CMAJ       Date:  2018-06-18       Impact factor: 8.262

Review 3.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

4.  Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.

Authors:  Miro Šimun Alebić; Nataša Stojanović; Dinka Pavičić Baldani; Lea Smirčić Duvnjak
Journal:  Endocrine       Date:  2016-08-03       Impact factor: 3.633

5.  Change in Birth Rate Before and After Bariatric Surgery in France.

Authors:  Claire Rives-Lange; Yannick Girardeau; Tigran Poghosyan; Cecile Ciangura; Muriel Coupaye; Jacky Nizard; Amel Ait-Boudaoud; Claire Carette; Anne-Sophie Jannot; Sébastien Czernichow
Journal:  Obes Surg       Date:  2021-07-12       Impact factor: 4.129

Review 6.  Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.

Authors:  Laura C Torchen
Journal:  Curr Diab Rep       Date:  2017-11-11       Impact factor: 4.810

7.  Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.

Authors:  Daniel A Dumesic; Alin L Akopians; Vanessa K Madrigal; Emmanuel Ramirez; Daniel J Margolis; Manoj K Sarma; Albert M Thomas; Tristan R Grogan; Rasha Haykal; Tery A Schooler; Bette L Okeya; David H Abbott; Gregorio D Chazenbalk
Journal:  J Clin Endocrinol Metab       Date:  2016-08-29       Impact factor: 5.958

Review 8.  Developmental Programming of Ovarian Functions and Dysfunctions.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Vitam Horm       Date:  2018-02-22       Impact factor: 3.421

Review 9.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

Review 10.  The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Authors:  Hannah E Young; Wendy E Ward
Journal:  Reprod Sci       Date:  2020-09-10       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.